Your browser doesn't support javascript.
loading
Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy.
Matsui, Hiroto; Hazama, Shoichi; Sakamoto, Kazuhiko; Shindo, Yoshitaro; Kanekiyo, Shinsuke; Nakashima, Masao; Matsukuma, Satoshi; Tokuhisa, Yoshihiro; Iida, Michihisa; Suzuki, Nobuaki; Yoshimura, Kiyoshi; Takeda, Shigeru; Ueno, Tomio; Yoshino, Shigefumi; Oka, Masaaki; Nagano, Hiroaki.
Afiliación
  • Matsui H; From the *Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine; †Department of Translational Research and Developmental Therapeutics Against Cancer, Yamaguchi University School of Medicine, Ube, Yamaguchi; ‡Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Japan, Tokyo; and §Oncology Center, Yamaguchi University Hospital, Ube, Japan.
Pancreas ; 46(8): 994-1002, 2017 09.
Article en En | MEDLINE | ID: mdl-28697053

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inmunoterapia Adoptiva / Desoxicitidina / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreas Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inmunoterapia Adoptiva / Desoxicitidina / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreas Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón